Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

T lymphocytes with a normal ADA gene accumulate after transplantation of transduced autologous umbilical cord blood CD34+ cells in ADA-deficient SCID neonates

Abstract

Adenosine deaminase-deficient severe combined immunodeficiency was the first disease investigated for gene therapy because of a postulated production or survival advantage for genecorrected T lymphocytes, which may overcome inefficient gene transfer. Four years after three newborns with this disease were given infusions of transduced autologous umbilical cord blood CD34+ cells, the frequency of gene-containing T lymphocytes has risen to 1–10%, whereas the frequencies of other hematopoietic and lymphoid cells containing the gene remain at 0.01–0.1%. Cessation of polyethylene glycol-conjugated adenosine deaminase enzyme replacement in one subject led to a decline in immune function, despite the persistence of gene-containing T lymphocytes. Thus, despite the long-term engraftment of transduced stem cells and selective accumulation of gene-containing T lymphocytes, improved gene transfer and expression will be needed to attain a therapeutic effect.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Gatti, R.A., Meuwissen, H.J., Allen H.D., Hong, R. & Good, R.A. Immunological re-constitution of sex-linked lymphopenic immunological deficiency. Lancet 2, 1366–1369 (1968).

    Article  CAS  Google Scholar 

  2. Parkman, R., Celfand, E.W., Rosen, F.S., Sanderson, A. & Hirschhorn, R. Severe combined immunodeficiency and adenosine deaminase. N. Engl. J. Med. 292, 714–719 (1975).

    Article  CAS  Google Scholar 

  3. Tjonnfjord, C.E., Steen, R., Veiby, O.P., Friedrich, W. & Egelan, T. Evidence for engraftment of donor-type multipotent CD34+ cells in a patient with selective T-lymphocyte reconstitution after bone marrow transplantation for B-SCID. Blood 84, 3584–3589 (1994).

    CAS  PubMed  Google Scholar 

  4. Hirschhorn, R. et al. Spontaneous in vivo reversion to normal of an inherited mutation in a patient with adenosine deaminase deficiency. Nature Genet. 13, 290–295 (1996).

    Article  CAS  Google Scholar 

  5. Stephan, V. et al. Atypical X-linked severe combined immunodeficiency due to possible spontaneous reversion of the genetic defect in T cells. N. Engl. J. Med. 335, 1563–1567 (1996).

    Article  CAS  Google Scholar 

  6. Kohn, D.B. et al. Engraftment of gene-modified cells from umbilical cord blood in neonates with adenosine deaminase deficiency. Nature Med., 1, 1017–1026 (1995).

    Article  CAS  Google Scholar 

  7. Blaese, R.M. et al. T lymphocyte-directed gene therapy for ADA- SCID: Initial trial results after 4 years. Science 270, 475–480 (1995).

    Article  CAS  Google Scholar 

  8. Bordignon, C. et al. Gene therapy in peripheral blood lymphocytes and bone marrow for ADA- immunodeficient patients. Science 270, 470–475 (1995).

    Article  CAS  Google Scholar 

  9. Hoogerbrugge, P.M. et al. Bone marrow gene transfer in three patients with adenosine deaminase deficiency. Cene Ther. 3, 179–183 (1996).

    CAS  Google Scholar 

  10. Hershfield, M.S. PEG-ADA: an alternative to haploidentical bone marrow transplantation and an adjunct to gene therapy for adenosine deaminase deficiency. Hum. Mutat. 5, 107–112 (1995).

    Article  CAS  Google Scholar 

  11. Hershfield, M.S. PEG-ADA replacement therapy for adenosine deaminase deficiency: an update after 8.5 years. Clin. Immunol. Immunopathol. 76, S228–232 (1995).

    Article  CAS  Google Scholar 

  12. Weinberg, K. et al. T lymphocyte ontogeny in adenosine deaminase-deficient severe combined immunodeficiency after treatment with polyethylene glycol-modified adenosine deaminase. J. Clin. Invest. 92, 596–602 (1993).

    Article  CAS  Google Scholar 

  13. Hershfield, M.S. & Mitchell, B.S. in The Metabolic and Molecular Bases of Inherited Disease. 7th edition, (eds. Scriver, C.S., Beaudet, A.L., Sly, W.S. St Valle, D.). 1725–1768 (McGraw-Hill, New York, 1995).

    Google Scholar 

  14. Bollinger, M.E. et al. Brief report: hepatic dysfunction as a complication of adenosine deaminase deficiency. N. Engl. J. Med. 334, 1367–1371 (1996).

    Article  Google Scholar 

  15. Hirschhorn, R. Overview of biochemical abnormalities and molecular genetics of adenosine deaminase deficiency. Pediatr. Res. 33 (Suppl), S35–S41 (1993).

    Article  CAS  Google Scholar 

  16. Ferrari, G. et al. An in vivo model of somatic cell gene therapy for human severe combined immunodeficiency. Science 251,1363–1366 (1991).

    Article  Google Scholar 

  17. Tsichlis, P.N. Oncogenesis by Moloney murine leukemia virus. Anticancer Res. 7, 171–180 (1987).

    CAS  PubMed  Google Scholar 

  18. DesGroseillers, L. & Jolicoeur, P. Mapping the viral sequences conferring leuke-mogenicity and disease specificity in Moloney and amphotropic murine leukemia viruses. J. Virol. 52, 448–456 (1984).

    CAS  PubMed  PubMed Central  Google Scholar 

  19. Agarwal, M., Austin, T.W., Morel, F., Chen, J., Bohnlein, E. & Plavec, I. Scaffold attachment region-mediated enhancement of retroviral expression in primary T cells. J. Virol. 72, 3720–3728 (1998).

    CAS  PubMed  PubMed Central  Google Scholar 

  20. Ruhl, E., Lum, L.G. & Trevor, K.T. T cell activation status modulates retrovirus-mediated gene expression. Blood 90 (Suppl 1) 417b (1997).

    Google Scholar 

  21. Hock, R.A., Miller, A.D. & Osborne, W.R. Expression of human adenosine deaminase from various strong promoters after gene transfer into human hematopoietic cell lines. Blood 74, 876–881 (1989).

    CAS  Google Scholar 

  22. Miller, A.D. & Buttimore, C. Redesign of retrovirus packaging cell lines to avoid recombination leading to helper virus production. Mol. Cell Biol. 6, 2895– 2902 (1986).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kohn, D., Hershfield, M., Carbonaro, D. et al. T lymphocytes with a normal ADA gene accumulate after transplantation of transduced autologous umbilical cord blood CD34+ cells in ADA-deficient SCID neonates. Nat Med 4, 775–780 (1998). https://doi.org/10.1038/nm0798-775

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nm0798-775

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing